Literature DB >> 34561613

Brain regions susceptible to alpha-synuclein spreading.

Yu-Jie Guo1,2, Huan Xiong1, Kang Chen1, Jin-Jun Zou1, Peng Lei3.   

Abstract

The spreading of misfolded alpha-synuclein (α-syn) protein has been observed in animal models of Parkinson's disease (PD) and other α-synucleinopathies that mimic human PD pathologies. In animal models, the spreading of α-syn has been associated with motor dysfunction and neuronal death. However, variability in both susceptible brain regions and cellular populations limits our understanding of the consequences of α-syn spreading and the development of associated therapies. Here, we have reviewed the physiological and pathological functions of α-syn and summarized the susceptible brain regions and cell types identified from human postmortem studies and exogenous α-syn injection-based animal models. We have reviewed the methods for inducing α-syn aggregation, the specific hosts, the inoculation sites, the routes of propagation, and other experimental settings that may affect the spreading pattern of α-syn, as reported in current studies. Understanding the spread of α-syn to produce a consistent PD animal model is vital for future drug discovery.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34561613     DOI: 10.1038/s41380-021-01296-7

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  179 in total

1.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

2.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

4.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

5.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal.

Authors:  L Maroteaux; J T Campanelli; R H Scheller
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

6.  Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of alpha-synuclein, a molecular chaperone.

Authors:  Sang Myun Park; Han Young Jung; Thomas D Kim; Jeon Han Park; Chul-Hak Yang; Jongsun Kim
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

7.  Characterization of α-synuclein N-terminal domain as a novel cellular phosphatidic acid sensor.

Authors:  Haruka Yamada; Satoru Mizuno; Shotaro Honda; Daisuke Takahashi; Fumio Sakane
Journal:  FEBS J       Date:  2019-11-28       Impact factor: 5.542

Review 8.  Physiological and pathological properties of alpha-synuclein.

Authors:  G K Tofaris; M G Spillantini
Journal:  Cell Mol Life Sci       Date:  2007-09       Impact factor: 9.261

9.  Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.

Authors:  Tritia R Yamasaki; Brandon B Holmes; Jennifer L Furman; Dhruva D Dhavale; Bryant W Su; Eun-Suk Song; Nigel J Cairns; Paul T Kotzbauer; Marc I Diamond
Journal:  J Biol Chem       Date:  2018-11-26       Impact factor: 5.157

10.  Transmission of multiple system atrophy prions to transgenic mice.

Authors:  Joel C Watts; Kurt Giles; Abby Oehler; Lefkos Middleton; David T Dexter; Steve M Gentleman; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

View more
  4 in total

Review 1.  Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges.

Authors:  Francesco Agostini; Anna Masato; Luigi Bubacco; Marco Bisaglia
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

2.  Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease.

Authors:  Mingxia Bi; Xixun Du; Xue Xiao; Yingying Dai; Qian Jiao; Xi Chen; Lingqiang Zhang; Hong Jiang
Journal:  Redox Biol       Date:  2021-10-14       Impact factor: 11.799

Review 3.  Oligomeropathies, inflammation and prion protein binding.

Authors:  Gianluigi Forloni; Pietro La Vitola; Claudia Balducci
Journal:  Front Neurosci       Date:  2022-08-23       Impact factor: 5.152

4.  Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence.

Authors:  Alexandre Henriques; Laura Rouvière; Elodie Giorla; Clémence Farrugia; Bilal El Waly; Philippe Poindron; Noëlle Callizot
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.